POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $21,000 | -50.0% | 8,421 | -10.5% | 0.00% | – |
Q1 2022 | $42,000 | -78.0% | 9,407 | -66.6% | 0.00% | – |
Q4 2021 | $191,000 | -30.3% | 28,178 | -25.2% | 0.00% | – |
Q3 2021 | $274,000 | -29.9% | 37,662 | -3.7% | 0.00% | -100.0% |
Q2 2021 | $391,000 | +171.5% | 39,127 | +157.6% | 0.00% | – |
Q1 2021 | $144,000 | – | 15,188 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
Knott David M Jr | 140,921 | $248 | 0.10% |
XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
Atom Investors LP | 49,413 | $86,967 | 0.03% |
EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |